These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1241989)

  • 1. [Treatment of kidney diseases with non-steroid anti-inflammatory drugs. I. Antiproteinuric effects of indomethacin].
    Hamada A
    Nihon Jinzo Gakkai Shi; 1975 Dec; 17(12):973-94. PubMed ID: 1241989
    [No Abstract]   [Full Text] [Related]  

  • 2. [Indomethacin in the treatment of glomerulonephritis].
    Tomilina NA; Biriukova LS
    Sov Med; 1983; (9):104-6. PubMed ID: 6648668
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of corticosteroid and indomethacin treatment on proteinuria].
    Michielsen P; Lambert PP
    Bull Mem Soc Med Hop Paris; 1967 Feb; 118(3):217-32. PubMed ID: 6058837
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiproteinuric effect of indomethacin and dipyridamole in various glomerulopathies of adults.
    Banerjee S; Sharma VK; Pareek SK; Ratnu KS
    J Assoc Physicians India; 1985 Nov; 33(11):716-7. PubMed ID: 4093385
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of glomerulonephritis with indomethacin and heparin.
    Suc JM; Conte J; Mignon-Conte
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):927-47. PubMed ID: 4803319
    [No Abstract]   [Full Text] [Related]  

  • 6. [Indomethacin in the therapy of prolonged or chronic glomerulonephritis and of the nephrotic syndrome].
    Campanacci L; Gambari P; Castellani A; Huber W
    Clin Ter; 1972 Apr; 61(1):31-46. PubMed ID: 5039599
    [No Abstract]   [Full Text] [Related]  

  • 7. Urinary excretion of fibrinogen-fibrin-related antigen in glomerulonephritis: effect of indomethacin.
    Dotremont G; Vermylen J; Donati MB; Van Damme B; Michielsen P
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):829-44. PubMed ID: 4803317
    [No Abstract]   [Full Text] [Related]  

  • 8. [Indomethacin in nephropathies in children. Apropos of 21 cases].
    Pierron H; Manassero J; Vaillaud JC; Paglia R; Orsini A
    Pediatrie; 1971 Mar; 26(2):167-73. PubMed ID: 5554434
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the use of indomethacin in the treatment of renal diseases in childhood].
    Varese LA; Antoniola P
    Minerva Pediatr; 1970 Jul; 22(28):1440-3. PubMed ID: 5515768
    [No Abstract]   [Full Text] [Related]  

  • 10. [Indomethacin in the treatment of chronic glomerulonephritis].
    Androsova SO; Kutyrina IM
    Ter Arkh; 1982; 54(7):46-8. PubMed ID: 7135222
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of treatment with corticosteroids and indomethacin on proteinuria].
    Michielsen P; Lambert PP
    J Urol Nephrol (Paris); 1967; 73(4):340-55. PubMed ID: 6066085
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of a new anti-inflammatory agent, bucloxic acid, in the treatment of chronic glomerular nephropathies.
    Lagrue G; Masbernard A; Giudicelli C; Hirbec G
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1434-9. PubMed ID: 4614821
    [No Abstract]   [Full Text] [Related]  

  • 13. [Long-term treatment of glomerulonephritis with indomethacin with special regard to quantity and selectivity of proteinuria].
    Fünistück R; Stein G; Krohs G; Sperschneider H; Stelzner A; Süsse I; Waldmann G
    Z Urol Nephrol; 1978 Jun; 71(6):375-83. PubMed ID: 98929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective cyclooxygenase-2 (COX-2) inhibition reduces proteinuria in renal patients.
    Vogt L; de Zeeuw D; Woittiez AJ; Navis G
    Nephrol Dial Transplant; 2009 Apr; 24(4):1182-9. PubMed ID: 19037084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of indomethacin on the course of glomerulonephritis].
    Bernheim JL; Pokroy N; Myers BD
    Nouv Presse Med; 1976 Nov; 5(38):2531-2. PubMed ID: 980763
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative study on the activity of various anti-inflammatory agents in chronically developing glomerulonephritis].
    Giudicelli CP; Lagrue G; Masbernard A; Hirbec G
    J Urol Nephrol (Paris); 1975 Sep; 81(9):673-90. PubMed ID: 1243552
    [No Abstract]   [Full Text] [Related]  

  • 17. [Histological course of diffuse proliferative glomerulonephritis treated with indomethacin].
    Michielsen P; Verberckmoes R; Desmet V; Hermerijckx W
    J Urol Nephrol (Paris); 1969; 75(4):315-8. PubMed ID: 5370830
    [No Abstract]   [Full Text] [Related]  

  • 18. [Course of nephropathy in systemic lupus erythematosus . Influence of the treatment on clinical symptoms, renal function and histology].
    Zech P; Richard P; Blanc-Brunat N; Labeeuw M; Colon S; Pozet N; Dupont E; Fries D; Traeger J
    J Urol Nephrol (Paris); 1972 Dec; 78(12):987-93. PubMed ID: 4540960
    [No Abstract]   [Full Text] [Related]  

  • 19. Proteinuria and nonsteroid anti-inflammatory drugs.
    Michielsen P; Varenterghem Y
    Adv Nephrol Necker Hosp; 1983; 12():139-50. PubMed ID: 6404132
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of indomethacin and selective cyclooxygenase-2 inhibitors on proteinuria and renal function in patients with AA type renal amyloidosis.
    Kahvecioglu S; Dilek K; Akdag I; Gullulu M; Demircan C; Ersoy A; Yurtkuran M
    Nephrology (Carlton); 2006 Jun; 11(3):232-7. PubMed ID: 16756637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.